Evaxion Biotech A/S (EVAX) Earnings Date, Estimates & Call Transcripts $2.93 +0.04 (+1.38%) As of 01:13 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Evaxion Biotech A/S Earnings Summary Evaxion Biotech A/S announced Q1 2025 earnings on May 27, 2025, reporting an EPS of -$0.29, which beat the consensus estimate of -$0.65 by $0.36. With a trailing EPS of -$1.16, Evaxion Biotech A/S's earnings are expected to decrease next year, from ($0.15) to ($0.67) per share. Upcoming Q2 Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (May. 27) -$0.65 Actual EPS (May. 27) -$0.29 Beat By $0.36 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Press Release (6-K)EVAX Upcoming EarningsEvaxion Biotech A/S's next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules. Powered by Get Evaxion Biotech A/S Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Evaxion Biotech A/S and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataEVAX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EVAX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Evaxion Biotech A/S Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.65-$0.65-$0.65Q2 20251-$0.50-$0.50-$0.50Q3 20251-$0.50-$0.50-$0.50Q4 20251-$0.50-$0.50-$0.50 FY 2025 4 -$2.15 -$2.15 -$2.15 Q1 20261-$0.50-$0.50-$0.50Q2 20261-$0.50-$0.50-$0.50Q3 20261$0.00$0.00$0.00Q4 20261$0.00$0.00$0.00 Evaxion Biotech A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------5/27/2025Q1 2025-$0.65-$0.29+$0.36-$0.29$0.06M-4/1/2025Q4 2024-$0.26-$0.07+$0.19-$0.07$1.66M$0.12M10/31/2024Q3 2024-$0.60-$0.20+$0.40-$0.04$0.19M$3.02M8/14/2024Q2 2024$0.10-$0.60 -$0.70-$0.12$0.10M$0.15M5/28/2024Q1 2024-$0.15+$0.15$0.03-$0.05M3/27/2024Q4 2023--$0.80 -$0.80-$0.16-$0.07M12/19/2023Q3 2023-$9.50-$10.50 -$1.00-$0.21--8/22/2023Q2 2023-$11.00-$10.50+$0.50-$0.21-- Evaxion Biotech A/S Earnings - Frequently Asked Questions When is Evaxion Biotech A/S's earnings date? Evaxion Biotech A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on EVAX's earnings history. Did Evaxion Biotech A/S beat their earnings estimates last quarter? In the previous quarter, Evaxion Biotech A/S (NASDAQ:EVAX) reported ($0.29) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.65) by $0.36. Learn more on analysts' earnings estimate vs. EVAX's actual earnings. How can I listen to Evaxion Biotech A/S's earnings conference call? The conference call for Evaxion Biotech A/S's latest earnings report can be listened to online. Listen to Conference Call How can I read Evaxion Biotech A/S's conference call transcript? The conference call transcript for Evaxion Biotech A/S's latest earnings report can be read online. Read Transcript How much revenue does Evaxion Biotech A/S generate each year? Evaxion Biotech A/S (NASDAQ:EVAX) has a recorded annual revenue of $3.29 million. How much profit does Evaxion Biotech A/S generate each year? Evaxion Biotech A/S (NASDAQ:EVAX) has a recorded net income of -$22.12 million. EVAX has generated -$1.16 earnings per share over the last four quarters. What is Evaxion Biotech A/S's EPS forecast for next year? Evaxion Biotech A/S's earnings are expected to decrease from ($0.15) per share to ($0.67) per share in the next year. More Earnings Resources from MarketBeat Related Companies Leap Therapeutics Earnings MEI Pharma Earnings AlloVir Earnings Flora Growth Earnings VYNE Therapeutics Earnings Ainos Earnings Synlogic Earnings Edesa Biotech Earnings Eterna Therapeutics Earnings BioLineRx Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:EVAX) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
